Brief: Strides Pharma Science Says Unit Receives USFDA Approval For Fluoxetine Tabs
09/04/2024 04:22
April 9 (Reuters) - Strides Pharma Science Ltd
SRID.NS :
* STRIDES RECEIVES USFDA APPROVAL FOR FLUOXETINE TABS 10 MG
AND 20
MG
Source text for Eikon: ID:nBSE6GNL4V
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees